Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide
2014 · Breast Cancer Research · 391 citations
https://doi.org/10.1186/bcr3599
J
Jennifer K. Richer
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
525
Papers
9.9K
Citations
55
h-index
95
i10-index
Jennifer K. Richer is an academic researcher from University of Colorado Anschutz Medical Campus. The author has contributed to research in topics: Tryptophan and brain disorders & Estrogen and related hormone effects & Immune cells in cancer. The author has an h-index of 55, co-authored 447 publications.
ORCID: 0000-0002-9960-0991Papers by this author
worksInsulin receptor substrates mediate distinct biological responses to insulin-like growth factor receptor activation in breast cancer cells
2006 · British Journal of Cancer · 118 citations
https://doi.org/10.1038/sj.bjc.6603354
Androgen Receptor Supports an Anchorage-Independent, Cancer Stem Cell-like Population in Triple-Negative Breast Cancer
2017 · Cancer Research · 85 citations
https://doi.org/10.1158/0008-5472.can-16-3240
Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a
2014 · Oncogene · 73 citations
https://doi.org/10.1038/onc.2014.298
Targeting Androgen Receptor in Treating HER2 Positive Breast Cancer
2017 · Scientific Reports · 72 citations
https://doi.org/10.1038/s41598-017-14607-2
Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells
2005 · The Journal of Steroid Biochemistry and Molecular Biology · 60 citations
https://doi.org/10.1016/j.jsbmb.2005.06.032
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat